Dapagliflozin Versus a Dipeptidyl Peptidase 4 Inhibitor (DPP4) Both Added to Metformin in Patients with Type 2 Diabetes Mellitus (T2DM)- Impact on Health, Quality of Life and Costs in the Turkish Clinical Setting
Abstract
Authors
S Malhan S Guler I Yetkin TJ Ignacio B Verheggen M Charokopou